Robert A. Ashley - Net Worth and Insider Trading

Robert A. Ashley Net Worth

The estimated net worth of Robert A. Ashley is at least $58 dollars as of 2024-11-13. Robert A. Ashley is the Chief Technical Officer, EVP of Immunic Inc and owns about 50 shares of Immunic Inc (IMUX) stock worth over $58. Details can be seen in Robert A. Ashley's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert A. Ashley has not made any transactions after 2017-06-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Robert A. Ashley

To

Robert A. Ashley Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert A. Ashley owns 1 companies in total, including Immunic Inc (IMUX) .

Click here to see the complete history of Robert A. Ashley’s form 4 insider trades.

Insider Ownership Summary of Robert A. Ashley

Ticker Comapny Transaction Date Type of Owner
IMUX Immunic Inc 2017-06-09 See Remarks

Robert A. Ashley Latest Holdings Summary

Robert A. Ashley currently owns a total of 1 stock. Robert A. Ashley owns 50 shares of Immunic Inc (IMUX) as of June 9, 2017, with a value of $58.

Latest Holdings of Robert A. Ashley

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
IMUX Immunic Inc 2017-06-09 50 1.15 58

Holding Weightings of Robert A. Ashley


Robert A. Ashley Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert A. Ashley has made a total of 0 transactions in Immunic Inc (IMUX) over the past 5 years. The most-recent trade in Immunic Inc is the acquisition of 50 shares on June 9, 2017, which cost Robert A. Ashley around $6,360.

Insider Trading History of Robert A. Ashley

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert A. Ashley Trading Performance

GuruFocus tracks the stock performance after each of Robert A. Ashley's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert A. Ashley is 7.81%. GuruFocus also compares Robert A. Ashley's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert A. Ashley within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Robert A. Ashley's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Robert A. Ashley

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -9.38 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -9.11 LIMIT LIMIT LIMIT LIMIT LIMIT

Robert A. Ashley Ownership Network

Ownership Network List of Robert A. Ashley

No Data

Ownership Network Relation of Robert A. Ashley

Insider Network Chart

Robert A. Ashley Owned Company Details

What does Immunic Inc do?

Who are the key executives at Immunic Inc?

Robert A. Ashley is the See Remarks of Immunic Inc. Other key executives at Immunic Inc include director & CEO & President Daniel Vitt , PAO and Controller Glenn Whaley , and Chief Medical Officer Andreas Muehler .

Immunic Inc (IMUX) Insider Trades Summary

Over the past 18 months, Robert A. Ashley made no insider transaction in Immunic Inc (IMUX). Other recent insider transactions involving Immunic Inc (IMUX) include a net purchase of 14,000 shares made by Daniel Vitt , and a net purchase of 5,000 shares made by Glenn Whaley .

In summary, during the past 3 months, insiders sold 0 shares of Immunic Inc (IMUX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immunic Inc (IMUX) were sold and 19,000 shares were bought by its insiders, resulting in a net purchase of 19,000 shares.

Immunic Inc (IMUX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Immunic Inc Insider Transactions

No Available Data

Robert A. Ashley Mailing Address

Above is the net worth, insider trading, and ownership report for Robert A. Ashley. You might contact Robert A. Ashley via mailing address: C/o Vital Therapies, Inc., 15010 Avenue Of Science, Suite 200, San Diego Ca 92128.